Kendall Capital Management Emergent Bio Solutions Inc. Transaction History

Kendall Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$11.0 - $21.45 $14,080 - $27,456	-1,280 Reduced 11.23%	10,115 $119,000
Q2 2022 Jul 29, 2022	SELL	$27.42 - $43.63 $5,209 - $8,289	-190 Reduced 1.64%	11,395 $354,000
Q1 2022 May 06, 2022	BUY	$36.48 - $52.22 $19,152 - $27,415	525 Added 4.75%	11,585 $476,000
Q4 2021 Jan 28, 2022	BUY	$33.11 - $55.01 $101,151 - $168,055	3,055 Added 38.16%	11,060 $481,000
Q3 2021 Nov 05, 2021	BUY	$50.07 - $66.05 $180,752 - $238,440	3,610 Added 82.14%	8,005 $401,000
Q2 2021 Jul 30, 2021	BUY	$56.61 - $80.46 $248,800 - $353,621	4,395 New	4,395 $277,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

Stay updated on Kendall Capital Management with notifications on news.